Study objectives To provide a systematic overview of the literature investigating patient and
tumor factors that are predictive of survival for patients with non-small cell lung cancer …

Lung cancer is the leading cause of cancer-related death in men and women in the United
States, accounting for approximately 28% of total cancer deaths in 2010 despite comprising …

Successful treatment decisions in cancer depend on the accurate assessment of patient risk.
To improve our understanding of the molecular alterations that underlie deadly …

Many cancers possess an incorrect number of chromosomes, a state described as
aneuploidy. Aneuploidy is often caused by Chromosomal Instability (CIN), a process of …

BACKGROUND A fundamental property of malignant tumors is increased glucose
metabolism, which can be estimated by imaging the glucose analog fluorodeoxyglucose …

Introduction to Flow Cytometry Page 1 Introduction to Flow Cytometry Jesse Manuel Jaso,
MD 7/28/2015 Page 2 Flow Cytometry • Flow cytometry is the measurement of single cells …

Kidney-type glutaminase (GLS) and liver-type glutaminase (GLS2) are dysregulated in many
cancers, making them appealing targets for cancer therapy. However, their use as …

PURPOSE: The aim of this study was to investigate the prognostic importance of codon 12 K-
ras mutations in patients with early-stage non–small-cell lung cancer (NSCLC). PATIENTS …

Flow cytometric study has been used to measure the cellular DNA content of solid tumors for
the last decade, and of paraffin‐embedded tumor specimens for the last 5 years. Ploidy and …

We attempted to clarify what factors predominantly influence the survival of patients with non-
small-cell lung cancer in each pathologic stage on the basis of information generally …